Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma | |
Jin, Chunxiang; Wang, Yang; Sui, Guoqing; Teng, Dengke; Wang, Qimeihui; Qu, Jia; Zhu, Lingyu; Ran, Haitao; Wang, Zhigang; Wang, Hui | |
刊名 | BIOMATERIALS SCIENCE |
2019 | |
卷号 | 7期号:1 |
ISSN号 | 2047-4830 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3511438 |
专题 | 吉林大学白求恩第三医院 |
推荐引用方式 GB/T 7714 | Jin, Chunxiang,Wang, Yang,Sui, Guoqing,et al. Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma[J]. BIOMATERIALS SCIENCE,2019,7(1). |
APA | Jin, Chunxiang.,Wang, Yang.,Sui, Guoqing.,Teng, Dengke.,Wang, Qimeihui.,...&Wang, Hui.(2019).Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma.BIOMATERIALS SCIENCE,7(1). |
MLA | Jin, Chunxiang,et al."Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma".BIOMATERIALS SCIENCE 7.1(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论